|
[1]
|
Cheruvattath, R. and Balan, V. (2007) Infections in Patients with End-Stage Liver Disease. Journal of Clinical Gastro-enterology, 41, 403-411. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
陈韬, 宁琴. 终末期肝病合并感染诊治的热点与难点[J]. 中华临床感染病杂志, 2017, 10(5): 389-393.
|
|
[3]
|
李秀喜. 终末期肝病合并感染诊治的难点分析[J]. 医学食疗与健康, 2021, 19(13): 216-217.
|
|
[4]
|
Haep, N., Florentino, R.M., Squires, J.E., et al. (2021) The Inside-Out of End-Stage Liver Disease: Hepatocytes Are the Keystone. Seminars in Liver Disease, 41, 213-224. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Alexopoulou, A., Vasilieva, L., Agiasotelli, D., et al. (2015) Fungal Infections in Patients with Cirrhosis. Journal of Hepatology, 63, 1043-1045. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Wang, R., Tang, R., Li, B., et al. (2021) Gut Microbiome, Liver Immunology, and Liver Diseases. Cellular & Molecular Immunology, 18, 4-17. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Barros, N., Rosenblatt, R.E., Phipps, M.M., et al. (2023) Inva-sive Fungal Infections in Liver Diseases. Hepatology Communications, 7, e0216. [Google Scholar] [CrossRef]
|
|
[8]
|
Nasr, P., Forsgren, M., Balkhed, W., et al. (2023) A Rapid, Non-Invasive, Clinical Surveillance for CachExia, Sarcopenia, Portal Hypertension, and Hepatocellular Carcinoma in End-Stage Liver Disease: The ACCESS-ESLD Study Protocol. BMC Gastroenterology, 23, Article No. 454. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Ruf, A., Dirchwolf, M. and Freeman, R.B. (2022) From Child-Pugh to MELD Score and Beyond: Taking a Walk down Memory Lane. Annals of Hepatology, 27, Article ID: 100535. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Kim, W.R., Mannalithara, A., Heimbach, J.K., et al. (2021) MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era. Gastroenterology, 161, 1887-1895.e4. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
王艳斌, 张婷, 谢雯, 等. 强化健康教育措施对住院肝病患者继发胃肠道感染的预防效果及临床价值[J]. 中国煤炭工业医学杂志, 2015, 18(6): 978-981.
|
|
[12]
|
Cai, J., Zhang, M., Han, T., et al. (2017) Characteristics of Infection and Its Impact on Short-Term Outcome in Patients with Acute-on-Chronic Liver Failure. Medicine (Baltimore), 96, e8057. [Google Scholar] [CrossRef]
|
|
[13]
|
Morales-Arráez, D., Ventura-Cots, M., Altamirano, J., et al. (2022) The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study. American Journal of Gastroenterology, 117, 301-310. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Hassan, E.A., Abd El-Rehim, A.S., Hassany, S.M., et al. (2014) Fungal Infection in Patients with End-Stage Liver Disease: Low Frequency or Low Index of Suspicion. Interna-tional Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases, 23, 69-74. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Balzan, S., De Almeida Quadros, C., De Cleva, R., et al. (2007) Bacterial Translocation: Overview of Mechanisms and Clinical Impact. Journal of Gastroenterology and Hepa-tology, 22, 464-471. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
蔡晓娟, 沈毅, 朱晓红, 等. 整合终末期肝病模型在慢加急性肝功能衰竭预后判断及治疗中的应用[J]. 中华实验和临床感染病杂志(电子版), 2018, 12(5): 446-452.
|
|
[17]
|
Bassetti, M., Peghin, M., Carnelutti, A., et al. (2017) Clinical Characteristics and Predictors of Mortality in Cirrhotic Patients with Candidemia and Intra-Abdominal Candidiasis: A Multicenter Study. Intensive Care Medicine, 43, 509-518. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Karakike, E., Moreno, C. and Gustot, T. (2017) Infections in Se-vere Alcoholic Hepatitis. Annals of Gastroenterology, 30, 152-160.
|
|
[19]
|
Fernández, J., Acevedo, J., Wiest, R., et al. (2018) Bacterial and Fungal Infections in Acute-on-Chronic Liver Failure: Prevalence, Characteristics and Impact on Prognosis. Gut, 67, 1870-1880. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Bartoletti, M., Rinaldi, M., Pas-quini, Z., et al. (2021) Risk Factors for Candidaemia in Hospitalized Patients with Liver Cirrhosis: A Multicentre Case-Control-Control Study. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 27, 276-282. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Lass-Flörl, C. (2017) Current Challenges in the Diagnosis of Fungal Infections. Methods in Molecular Biology (Clifton, NJ), 1508, 3-15. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
梁东. 肝衰竭并发医院内真菌感染36例临床分析[J]. 中国热带医学, 2015, 15(12): 1510-1512.
|
|
[23]
|
Fiore, M. and Leone, S. (2016) Spontaneous Fungal Peritonitis: Epidemiolo-gy, Current Evidence and Future Prospective. World Journal of Gastroenterology, 22, 7742-7747. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Falcone, M., Massetti, A.P., Russo, A., et al. (2011) Invasive As-pergillosis in Patients with Liver Disease. Medical Mycology, 49, 406-413. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Prodanovic, H., Cracco, C., Massard, J., et al. (2007) Invasive Pul-monary Aspergillosis in Patients with Decompensated Cirrhosis: Case Series. BMC Gastroenterology, 7, Article No. 2. [Google Scholar] [CrossRef]
|
|
[26]
|
Lahmer, T., Peçanha-Pietrobom, P.M., Schmid, R.M., et al. (2022) Invasive Fungal Infections in Acute and Chronic Liver Impairment: A Systematic Review. Mycoses, 65, 140-151. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
吴文娟, 张友祥, 卢洪洲. 真菌定植与感染的认识[J]. 诊断学理论与实践, 2009, 8(5): 481-483.
|
|
[28]
|
苏海滨, 王慧芬, 林芳, 等. 肝衰竭合并真菌感染的调查分析[J]. 中华医院感染学杂志, 2009, 19(13): 1664-1667.
|
|
[29]
|
王宇, 许祥, 童晶晶, 等. 肝衰竭患者并发真菌感染病原学及影响因素[J]. 中华医院感染学杂志, 2020, 30(14): 2105-2109.
|
|
[30]
|
黄晶, 周凤英, 赵兰香. 73例肝病患者发生医院内真菌感染的调查报告[J]. 实用肝脏病杂志, 2005, 8(5): 293-294.
|
|
[31]
|
苏海滨, 王慧芬, 林芳, 等. 肝衰竭合并细菌和真菌感染的回顾性研究[J]. 中华实验和临床病毒学杂志, 2007, 21(3): 229-231.
|
|
[32]
|
Schmiedel, Y. and Zimmerli, S. (2016) Common Invasive Fungal Diseases: An Overview of Invasive Candidiasis, Aspergillosis, Cryptococcosis, and Pneumocystis pneumonia. Swiss Medical Weekly, 146, w14281. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Theocharidou, E., Agarwal, B., Jeffrey, G., et al. (2016) Early Inva-sive Fungal Infections and Colonization in Patients with Cirrhosis Admitted to the Intensive Care Unit. Clinical Microbi-ology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 22, 189.e1-.e7. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Drgona, L., Khachatryan, A., Stephens, J., et al. (2014) Clinical and Economic Burden of Invasive Fungal Diseases in Europe: Focus on Pre-Emptive and Empirical Treatment of Aspergillus and Candida Species. European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the Eu-ropean Society of Clinical Microbiology, 33, 7-21. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
黄祎, 李哲, 雷宇, 等. 102例终末期肝病患者并发侵袭性真菌感染的诊断、治疗研究[J]. 重庆医科大学学报, 2017, 42(7): 808-812.
|
|
[36]
|
Verma, N., Singh, S., Taneja, S., et al. (2019) Invasive Fungal Infections amongst Patients with Acute-on-Chronic Liver Failure at High Risk for Fungal Infections. Liver International, 39, 503-513. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Lin, L.N., Zhu, Y., Che, F.B., et al. (2013) Invasive Fungal Infections Sec-ondary to Acute-on-Chronic Liver Failure: A Retrospective Study. Mycoses, 56, 429-433. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Bajaj, J.S., Reddy, R.K., Tandon, P., et al. (2018) Prediction of Fungal In-fection Development and Their Impact on Survival Using the NACSELD Cohort. The American Journal of Gastroenter-ology, 113, 556-563. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Lahmer, T., Brandl, A., Rasch, S., et al. (2016) Fungal Peritonitis: Un-derestimated Disease in Critically Ill Patients with Liver Cirrhosis and Spontaneous Peritonitis. PLOS ONE, 11, e0158389. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Chen, J., Yang, Q., Huang, J., et al. (2013) Risk Factors for In-vasive Pulmonary Aspergillosis and Hospital Mortality in Acute-on-Chronic Liver Failure Patients: A Retrospec-tive-Cohort Study. International Journal of Medical Sciences, 10, 1625-1631. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Soriano, A., Honore, P.M., Puerta-Alcalde, P., et al. (2023) Invasive Can-didiasis: Current Clinical Challenges and Unmet Needs in Adult Populations. Journal of Antimicrobial Chemotherapy, 78, 1569-1585. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Paya, C.V. (2001) Prevention of Fungal and Hepatitis Virus Infections in Liver Transplantation. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 33, S47-S52. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Suleyman, G. and Alangaden, G.J. (2021) Nosocomial Fungal Infections: Ep-idemiology, Infection Control, and Prevention. Infectious Disease Clinics of North America, 35, 1027-1053. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Almirante, B., Rodríguez, D., Park, B.J., et al. (2005) Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003. Journal of Clinical Microbiology, 43, 1829-1835. [Google Scholar] [CrossRef]
|
|
[45]
|
Lahmer, T., Brandl, A., Rasch, S., et al. (2019) Prevalence and Outcome of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Liver Cirrhosis: An Observational Study. Scientific Reports, 9, Article No. 11919. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Levesque, E., Ait-Ammar, N., Dudau, D., et al. (2019) Invasive Pulmonary Aspergillosis in Cirrhotic Patients: Analysis of a 10-Year Clinical Experience. Annals of Intensive Care, 9, Article No. 31. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Saif, M.W. and Raj, M. (2006) Cryptococcal Peritonitis Compli-cating Hepatic Failure: Case Report and Review of the Literature. The Journal of Applied Research, 6, 43-50.
|
|
[48]
|
苏海滨, 胡瑾华, 李丽, 等. 重症肝病合并侵袭性真菌感染诊治专家共识[J]. 临床肝胆病杂志, 2022, 38(2): 311-317.
|
|
[49]
|
王宇, 胡瑾华. 肝衰竭合并真菌感染发病特点及预后影响因素[J]. 临床肝胆病杂志, 2019, 35(2): 419-423.
|
|
[50]
|
朱海洋, 高红伟, 孙会卿, 等. 肝衰竭患者真菌感染临床特点与干预措施[J]. 中华医院感染学杂志, 2015, 25(23): 5404-5405+5420.
|
|
[51]
|
Fang, W., Wu, J., Cheng, M., et al. (2023) Diagnosis of Invasive Fungal Infec-tions: Challenges and Recent Developments. Journal of Biomedical Science, 30, Article No. 42. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
George, B.J., Horvath, L.L. and Hospenthal, D.R. (2005) Effect of Inoculum Size on Detection of Candida Growth by the BACTEC 9240 Automated Blood Culture System Using Aer-obic and Anaerobic Media. Journal of Clinical Microbiology, 43, 433-435. [Google Scholar] [CrossRef]
|
|
[53]
|
Bassetti, M., Marchetti, M., Chakrabarti, A., et al. (2013) A Research Agenda on the Management of Intra-Abdominal Candidiasis: Results from a Consensus of Multinational Ex-perts. Intensive Care Medicine, 39, 2092-2106. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Posteraro, B., Tumbarello, M., De Pascale, G., et al. (2016) (1,3)-β-d-Glucan-Based Antifungal Treatment in Critically Ill Adults at High Risk of Candidaemia: An Observational Study. Journal of Antimicrobial Chemotherapy, 71, 2262- 2269. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Nucci, M., Nouér, S.A., Esteves, P., et al. (2016) Discontinuation of Empirical Antifungal Therapy in ICU Patients Using 1,3-β-d-Glucan. Journal of Antimicrobial Chemotherapy, 71, 2628-2633. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Bromuro, C., Posteraro, B., Murri, R., et al. (2023) Identification of Two Anti-Candida Antibodies Associated with the Survival of Patients with Candidemia. mBio, 15, e02769-23. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
White, P.L., Alanio, A., Brown, L., et al. (2022) An Overview of Us-ing Fungal DNA for the Diagnosis of Invasive Mycoses. Expert Review of Molecular Diagnostics, 22, 169-184. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Chen, H., Zhang, Y., Zheng, J., et al. (2021) Application of mNGS in the Etiological Diagnosis of Thoracic and Abdominal Infection in Patients with End-Stage Liver Disease. Frontiers in Cellular and Infection Microbiology, 11, Article ID: 741220. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Bassetti, M. and Bouza, E. (2017) Invasive Mould Infections in the ICU Setting: Complexities and Solutions. The Journal of Antimicrobial Chemotherapy, 72, i39-i47. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
徐贝雪, 刘泉波. 抗真菌药物临床应用及研究进展[J]. 现代医药卫生, 2022, 38(14): 2435-2440.
|
|
[61]
|
Spernovasilis, N. and Kofteridis, D.P. (2018) Pre-Existing Liver Disease and Toxicity of Antifungals. Journal of Fungi (Basel, Switzerland), 4, Article No. 133. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Wong-Beringer, A. and Kriengkauykiat, J. (2003) Systemic Antifungal Therapy: New Options, New Challenges. Pharmacotherapy, 23, 1441-1462. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Nivoix, Y., Ledoux, M.P. and Herbrecht, R. (2020) Antifun-gal Therapy: New and Evolving Therapies. Seminars in Respiratory and Critical Care Medicine, 41, 158-174. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
陈韬, 宁琴. 终末期肝病合并感染诊治专家共识(2021年版) [J]. 临床肝胆病杂志, 2022, 38(2): 304-310.
|
|
[65]
|
重症患者侵袭性真菌感染诊断与治疗指南(2007) [J]. 中华内科杂志, 2007, 46(11): 960-966.
|
|
[66]
|
Verma, A., Auzinger, G., Kantecki, M., et al. (2017) Safety and Efficacy of Anidulafungin for Fungal Infection in Patients with Liver Dysfunction or Multiorgan Failure. Open Forum Infectious Diseases, 4, ofw241. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Wells, C. and Lever, A.M. (1992) Dose-Dependent Fluconazole Hepato-toxicity Proven on Biopsy and Rechallenge. The Journal of Infection, 24, 111-112. [Google Scholar] [CrossRef]
|
|
[68]
|
(2018) Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy. Clinical Pharmacology and Therapeutics, 103, Article No. 349. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Veringa, A., Ter Avest, M., Touw, D.J., et al. (2016) Comment on: Util-ity of Voriconazole Therapeutic Drug Monitoring: A Meta-Analysis. The Journal of Antimicrobial Chemotherapy, 71, 3316-3317. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Ivanov, M., Ćirić, A. and Stojković, D. (2022) Emerging Antifungal Tar-gets and Strategies. International Journal of Molecular Sciences, 23, Article No. 2756. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Lo Re, V., Carbonari, D.M., Lewis, J.D., et al. (2016) Oral Azole An-tifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease Status. The American Jour-nal of Medicine, 129, 283-291.e5. [Google Scholar] [CrossRef] [PubMed]
|
|
[72]
|
Cornely, O.A., Duarte, R.F., Haider, S., et al. (2016) Phase 3 Pharmacokinetics and Safety Study of a Posaconazole Tablet Formulation in Patients at Risk for Invasive Fungal Disease. The Journal of Antimicrobial Chemotherapy, 71, 718-726. [Google Scholar] [CrossRef] [PubMed]
|
|
[73]
|
Mccarthy, M.W., Moriyama, B., Petraitiene, R., et al. (2018) Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole. Clinical Pharmacokinetics, 57, 1483-1491. [Google Scholar] [CrossRef] [PubMed]
|
|
[74]
|
Desai, A., Schmitt-Hoffmann, A.H., Mujais, S., et al. (2016) Population Pharmacokinetics of Isavuconazole in Subjects with Mild or Moderate Hepatic Impairment. Antimicrobial Agents and Chemotherapy, 60, 3025-3031. [Google Scholar] [CrossRef]
|
|
[75]
|
Desai, A.V., Kovanda, L.L., Hope, W.W., et al. (2017) Expo-sure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi. An-timicrobial Agents and Chemotherapy, 61, e01034-17. [Google Scholar] [CrossRef]
|
|
[76]
|
Folk, A., Cotoraci, C., Balta, C., et al. (2016) Evaluation of Hepato-toxicity with Treatment Doses of Flucytosine and Amphotericin B for Invasive Fungal Infections. BioMed Research In-ternational, 2016, Article ID: 5398730. [Google Scholar] [CrossRef] [PubMed]
|